Long-standing type II diabetes mellitus is not a risk factor for slow gastric emptying in critically ill patients.

Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0342-4642 (Print) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE

Publication: New York : Springer Verlag
Original Publication: Berlin ; New York, Springer International.

Critical Illness* ; Gastric Emptying*; Diabetes Mellitus, Type 2/*physiopathology; APACHE ; Breath Tests ; Case-Control Studies ; Chi-Square Distribution ; Female ; Humans ; Male ; Middle Aged ; Respiration, Artificial ; Retrospective Studies ; Risk Factors

Objective: Delayed gastric emptying (GE) is common both in critical illness and in patients with diabetes mellitus (DM). The effect of DM on the incidence of slow GE in these patients is unknown. We evaluated the effect of DM on liquid GE in critically ill patients.
Methods: Retrospective analysis of GE using a standard [13C]octanoic acid breath test in 12 type 2 DM patients compared with (a) 44 critically ill patients without DM, including (b) a subgroup of 15 age- and sex-matched patients and (c) 15 healthy volunteers. We determined the gastric emptying coefficient (GEC) and the gastric half-emptying time (t50). Mean APACHE II scores, blood glucose levels and use of morphine were similar between patient groups.
Results: GE was faster in critically ill patients with DM (t50 122 +/- 11 min, GEC: 3.8 +/- 0.3) than in patients without DM (t50 168 +/- 16 min, GEC 2.8 +/- 0.1) and in age- and sex-matched controls (t50 165 +/- 13 min, GEC 2.7 +/- 0.2) and was similar to that in healthy volunteers (t50 148 +/- 13 min, GEC 3.5 +/- 0.1). The proportion of patients with slow emptying (GEC < 3.2) was greater in non-DM (all = 56%, matched = 60%) than in DM patients (25%) and healthy subjects (26%).
Conclusion: Long-standing type diabetes mellitus is not a risk factor for slow GE in critically ill patients.

Diabetes Care. 1996 May;19(5):468-71. (PMID: 8732711)
Diabet Med. 1996 Sep;13(9 Suppl 5):S16-22. (PMID: 8894465)
Dig Dis. 1990;8(1):23-36. (PMID: 2302821)
Chest. 2001 Apr;119(4):1222-41. (PMID: 11296191)
Am J Clin Nutr. 1988 Feb;47(2 Suppl):352-6. (PMID: 3124596)
Gastroenterology. 1993 Aug;105(2):382-90. (PMID: 8335193)
N Engl J Med. 1991 Jan 10;324(2):130-1. (PMID: 1984184)
Nucl Med Commun. 1996 Jan;17 (1):60-5. (PMID: 8692475)
Ann N Y Acad Sci. 1999 Apr 20;873:506-11. (PMID: 10372186)
Diabetes Care. 2001 Feb;24(2):371-81. (PMID: 11213895)
J Nucl Med. 1996 Oct;37(10 ):1643-8. (PMID: 8862300)
Am J Physiol. 1980 Aug;239(2):G71-6. (PMID: 6996495)
Dig Dis Sci. 1998 Mar;43(3):491-6. (PMID: 9539642)
Diabet Med. 1998 Dec;15(12):1022-7. (PMID: 9868975)
J Nucl Med. 1992 Aug;33(8):1496-500. (PMID: 1634941)
Eur J Gastroenterol Hepatol. 1996 Mar;8(3):211-7. (PMID: 8724019)
Diabetes Metab. 2001 Jun;27(3):357-64. (PMID: 11431601)
J Nucl Med. 1997 May;38(5):814-8. (PMID: 9170452)
J Diabetes Complications. 2001 May-Jun;15(3):128-34. (PMID: 11358681)
Crit Care Med. 1994 Mar;22(3):441-7. (PMID: 8124995)
Riv Eur Sci Med Farmacol. 1991 Sep-Dec;13(5-6):205-9. (PMID: 1819847)
Metabolism. 2003 Jul;52(7):815-20. (PMID: 12870154)
Z Gastroenterol. 2003 May;41(5):383-90. (PMID: 12772050)
Anaesth Intensive Care. 2001 Dec;29(6):619-22. (PMID: 11771607)
Gastroenterology. 1995 Sep;109(3):755-65. (PMID: 7657103)
Intensive Care Med. 1996 Dec;22(12):1339-44. (PMID: 8986483)
Crit Care Med. 2001 Sep;29(9):1744-9. (PMID: 11546976)
Crit Care Med. 1995 Jun;23(6):1055-60. (PMID: 7774216)
Ann Surg. 1980 Nov;192(5):604-13. (PMID: 6776917)
Diabetes Care. 2003 Nov;26(11):3116-22. (PMID: 14578248)
Gut. 2005 Oct;54(10):1384-90. (PMID: 15923669)

Date Created: 20060630 Date Completed: 20070208 Latest Revision: 20181113

20240628

10.1007/s00134-006-0228-0

16807708